Search

Search Constraints

You searched for: Issue Volume 55:Issue 8(2006)

Search Results

3. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease. Issue 8 (21st February 2006)

9. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Issue 8 (9th February 2006)